What does Ascendis pharma do?
We are a dynamic, growing biopharma company with offices in Denmark, Germany and the United States. We’re advancing programs both in endocrinology, where we have three rare disease product candidates in clinical development, and in oncology, where we are building a pipeline of candidates.
Where is ascendis Pharma located?
Copenhagen, Denmark
Company Snapshot Ascendis Pharma was founded in 2007 based on the innovative TransCon technology platform. We are headquartered in Copenhagen, Denmark and are publicly traded, following an initial public offering in 2015 (Nasdaq: ASND).
When was ascendis Pharma founded?
September 2006
Ascendis Pharma/Founded
What is TransCon technology?
TransCon is an innovative technology platform for drug development. It combines known biology with the benefits of prodrug and sustained-release technologies to potentially optimize therapeutic effect. This could mean enhancing efficacy, improving tolerability and convenience, or reducing caregiver burden.
Is ascendis health a good investment?
If you are looking for stocks with good return, Ascendis Health Limited stock can be a bad, high-risk 1-year investment option. Ascendis Health Limited real time quote is equal to 91.000 ZAR at 2021-10-14, but your current investment may be devalued in the future.
How many employees does ascendis Pharma have?
Company Growth (employees)
| Employees (est.) (Jul 2021) | 482 | |
|---|---|---|
| Website Visits (Apr 2021) | 7.7 k | |
| Share Price (Aug 2021) | $154.8 | (+4%) |
| Cybersecurity rating | A | More |
Should I buy ascendis shares?
Ascendis share prices have risen from under R15 in May 2015, to over R21 today, proving that the purchase of shares has yielded great returns for investors. This, along with a history of good dividends and stock market performance, should make Ascendis shares a very savvy buy in the current environment.